FDA issues Viagra ad warning letter

Share this article:
The FDA issued a warning letter to Pfizer for not mentioning the risks of impotence pill Viagra in a video ad on CNN.com.
 
The 30-second video showed a group of musicians singing “Viva Viagra” in a song about the benefits of the drug.

Pfizer said in published reports that a technical issue with the CNN website prevented the risk information from being displayed on a banner to accompany the video and that it has since pulled the ad.

“Pfizer discovered the error, notified the website of the error, and our understanding was that the website corrected its error immediately,” the company said in a statement.

Drugmakers are required to mention a drug's negative side effects in any advertisement that highlights benefits. Viagra's label warns of potential risks to patients with existing heart conditions as well as reported headaches and abnormal vision.

The FDA warning letter was dated April 16 and posted to the FDA's website April 21.

In the letter, DDMAC director Thomas Abrams wrote the Viagra ad “raises public health and safety concerns through its complete omission of risk information for Viagra.”
Share this article:

Email Newsletters

More in News

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi and partner Regeneron attached a $67.5-million priority review voucher to their experimental cholesterol drug alirocumab, making for a tighter race with Amgen.

HHS shows how diabetes adds up

HHS shows how diabetes adds up

A 2005-to-2010 survey shows diabetics 65-and-up juggle at least four co-morbid conditions and five medications for them.

AstraZenca beefs up respiratory portfolio

AstraZenca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.